VolitionRX Profit Margin

VolitionRX (VNRX) currently reports a profit margin of -997.46% as of March 2026. That compares with -1836.21% in the prior-year period — up 45.7% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore VolitionRX's profit margin history and peer comparisons.

VolitionRX's profit margin increased from -1836.21% to -997.46% — a 45.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

VolitionRX's profit margin of -997.46% is lower than the Healthcare sector average of 14.34%. That is roughly 7053.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but VolitionRX's current -997.46% should be judged against Healthcare norms (sector average: 14.34%) and against VNRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -997.46%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for VolitionRX, and consider following VNRX for alerts when major investors trade the stock.